Announced Exclusive Licensing Agreement with Viatris for Sotagliflozin in all Markets Outside of the U.S. and EuropeCompleted ZYNQUISTA™ FDA …
Lexicon Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
view original post